Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 12/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.35 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.34 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.34 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.34 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.34 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.34 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.34 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7135312 | 0.99 | HSD11B1 (0.38) | HSD11B1CYP2D6HDAC4GRIN2DGRIN3B | |
| SCHEMBL7082431 | 0.96 | HSD11B1 (0.38) | HSD11B1CYP2D6HDAC4GRIN2DGRIN3B | |
| Hydrochloric Acid SCHEMBL7082006 | 0.94 | HSD11B1 (0.38) | HSD11B1CYP2D6HDAC4GRIN2DGRIN3B | |
| SCHEMBL7080304 | 0.84 | HSD11B1 (0.38) | HSD11B1GRIN2DGRIN3BGRIN1GRIN2A | |
| Hydrochloric Acid SCHEMBL7079630 | 0.83 | HSD11B1 (0.38) | HSD11B1GRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL7079043 | 0.81 | HSD11B1 (0.37) | HSD11B1GRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL7079468 | 0.81 | HTR2A (0.37) | HSD11B1 | |
| SCHEMBL7082807 | 0.80 | HSD11B1 (0.38) | HSD11B1GRIN2DGRIN3BGRIN1GRIN2A | |
| Hydrochloric Acid SCHEMBL7191573 | 0.80 | HTR2C (0.39) | HSD11B1 | |
| Hydrochloric Acid SCHEMBL7079481 | 0.79 | HSD11B1 (0.37) | HSD11B1GRIN2DGRIN3BGRIN1GRIN2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2003064372-A1 | 2-ADAMANTYLALKYLAMINES AND THEIR USE IN THE TREATMENT OF CONDITIONS GENERALLY ASSOCIATED WITH ABNORMALITIES IN GLUTAMATERGIC TRANSMISSION | VERNALIS RESEARCH LIMITED (GB) | 2003-08-07 | — | — | WO | claimed |
| WO-2003064372-A1 | 2-ADAMANTYLALKYLAMINES AND THEIR USE IN THE TREATMENT OF CONDITIONS GENERALLY ASSOCIATED WITH ABNORMALITIES IN GLUTAMATERGIC TRANSMISSION | VERNALIS RESEARCH LIMITED (GB) | 2003-08-07 | — | — | WO | disclosed |